1 The ability of PD 128907 to activate dopamine receptors in the ventral tegmental area, substantia nigra pars compacta, and striatum was investigated by use of in vitro electrophysiological recodring and fast cyclic voltammetry. The affinity of a novel D-2 selective antagonist L-741,626 for recectors activated by this agonist ws measured to determine if its effects were mediated by D-2 or D-3 receptors. 2 The active (+) enantiomer of PD 128907 bound with high affinity and selectivity to rat D-3 dopamine receptors. The K-i values for (+)-PD 128907 were 620 nM at D-2, 1 nM at D-3 and 720 nM at D-4 receptors. 3 (+)-PD 128907 inhibited cell firing in both the ventral tegmental area and substantia nigra pars compacta with EC(50) values of 33 nM (pEC(50)=7.48+/-0.10, n=10) and 38 nM (pEC(50)=7.42+/-0.15, n=5), respectively. No effects of (+)-PD 128907 (100 nM) were observed on glutamate or GABA-mediated synaptic potentials elicited by focal bipolar stimulation. 4 L-741,626 antagonized these efects of (+)-PD 128907 in a concentration-dependent and surmountable manner with an affinity, determined from Schild analysis, of 20nM (pK(B)=7.71+/-0.14) in the ventral tegmental area and 11 nM (pK(B)=7.95+/-0.18) in the substantia nigra pars compacta. 5 (+)-PD128907 also inhibited dopamine release in the caudata-putamen with an EC(50) of 66 nM (n=5). The affinity of L-741,626 for these nerve terminal autoreceptors (pK(B)=7.71+/-0.06; =20 nM) was identical to that observed on midbrain dopamine neurons. 6 These data demonstrate that the D-3 receptor ligand (+)-PD 128907 is a potent agonis on rat midbrain dopamine neurones. However, its lack of reginal selectivity, and the high affinity of the selective D-2 receptor antagonist L-741,626 for receptors activated by (+)-PD 128907, was more consistent with an action on D-2 autoreceptors rather than upon a D-3 dopamine receptor subtype.